What researchers study
TB-500 is marketed as a thymosin-β4-related research peptide and is investigated primarily around cell migration, angiogenesis, connective tissue and wound-repair biology.
Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.
Potential side effects & unknowns
Human safety data for TB-500 itself are sparse. Human wound-healing studies of thymosin-β4 are not interchangeable with injected TB-500. For musculoskeletal use, recent reviews conclude that human evidence is lacking and safety, dosing and duration remain uncertain.
Research highlight
Thymosin-β4 research has shown faster repair in several wound models and some human topical wound studies. For TB-500 specifically, the evidence is predominantly preclinical, so claims of faster sports-injury recovery in people are not established.
Related video
Dr. Jones, DC: Doctor Explains How the FDA Vote Changes BPC-157, TB-500, KPV & MOTS-c
Additional commentary from Dr. Dean Jones, DC. This video is embedded for context and education; WILGO does not control or independently verify claims made in third-party videos.
Video hosted by YouTube. Opening or playing it may be subject to YouTube's privacy terms.
Looking for TB-500?
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.